Clinical Trial

Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

Name: Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication — clinical trial record (NCT06049654)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The VIVALL-2 study is a randomized trial to compare the self-expandable supra-annular Allegra and the balloon-expandable intra-annular Edwards transcatheter valve systems in patients with degenerated biological aortic surgical valve.

Trial Details

NCT Number	NCT06049654
Lead Sponsor	Fundación EPIC
Conditions	Aortic Valve Stenosis, Structural Valve Deterioration
Enrollment	104 participants
Start Date	2024-02-01
Primary Completion	2027-11-01 (estimated)
Study Completion	2027-11-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-05